share_log

EyePoint Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Ribeiro Ramiro

SEC announcement ·  Mar 5 06:43
Summary by Futu AI
EyePoint Pharmaceuticals, Inc. (EYPT) has reported an initial statement of beneficial ownership of securities filed by Chief Medical Officer Ramiro Ribeiro. The SEC Form 3, filed on March 1, 2024, indicates that Ribeiro has no beneficially owned securities at the time of the filing. The form, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, was signed by Ribeiro's attorney-in-fact, Ron Honig, on March 4, 2024. This filing is part of the standard regulatory requirements for officers of publicly traded companies to report their securities holdings and transactions to the SEC.
EyePoint Pharmaceuticals, Inc. (EYPT) has reported an initial statement of beneficial ownership of securities filed by Chief Medical Officer Ramiro Ribeiro. The SEC Form 3, filed on March 1, 2024, indicates that Ribeiro has no beneficially owned securities at the time of the filing. The form, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, was signed by Ribeiro's attorney-in-fact, Ron Honig, on March 4, 2024. This filing is part of the standard regulatory requirements for officers of publicly traded companies to report their securities holdings and transactions to the SEC.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.